Daré Bioscience, in collaboration with Strategic Science & Technologies, has announced positive topline data from a Phase 2b study evaluating Sildenafil Cream as a treatment for female sexual arousal disorder (FSAD). The study showed meaningful improvement in the Arousal-Sensation Domain of the Sexual Function Questionnaire for patients treated with Sildenafil Cream. Additionally, improvements were observed in secondary and exploratory endpoints related to…
Swedish women’s health company Gedea Biotech has raises €1.3M (14 MSEK) to further develop its pHyph, an innovative antibiotic-free treatment for vaginal infections. Vaginal infections affect over 400 million women annually. The fresh funds will support critical development activities, including ongoing proof-of-concept studies, clinical trials, and exploring the impact of pHyph on the vaginal microbiome. The funding round attracted current and new…
German DTC startup Dr. Vivien Karl, is taking strides towards improving women’s intimate health care, and their efforts have now been bolstered by a successful round of pre-seed funding. The company has secured €1.5M from both existing investors and new ones. Notably, Dieter von Holtzbrinck Ventures (DvH Ventures) joins the funding round as the new lead investor, with Tina Müller, the former…
Quinky, an Amsterdam-based sextech startup, is hoping to establish itself as a beacon for Gen Z by addressing the inadequacies of existing sexual and romantic relationship advice platforms. Geared primarily towards older demographics, most of these platforms leave the tech-savvy Gen Z stranded with unreliable sources of information. Quinky aims to rectify this by stepping into the scene as the “Duolingo of…
Rosy Wellness, a startup focusing on women’s sexual health, recently announced securing $1.2M in a bridge funding round, bringing its total funding to $4.2 million. The company aims to fill the gap in resources and treatments available for the 43% of women who suffer from sexual health problems, according to its CEO, Dr. Lyndsey Harper. Founded in 2018, Rosy Wellness has already…
Vice Ventures is a New York-based early stage venture capital fund that aims to deliver superior returns by investing in good companies operating in superficially “bad” industries including alcohol, cannabis, energy, harm-reducing nicotine, psychedelics, sextech, skill-based betting, sports betting, MDMA, and ketamine. The VC firm has now announced the closing of a second $25M fund. Vice Ventures Founding Partner Catharine Dockery started the…
Vella Bioscience whose Women’s Pleasure Serum has been granted the brands first patent for the use of cannabinoids in treating Antidepressant-Induced Female Sexual Dysfunction by the Patent and Trademark Office (USPTO). “Vella’s ability to do pharmaceutical-like research inside the sexual wellness consumer space is on full display with the grant of our first patent, and we expect several more to come,” said…
Christina Aguilera, the Grammy Award-winning singer-songwriter and entrepreneur, has been named Co-Founder and Chief Brand Advisor of Playground, a sexual wellness brand that creates innovative intimacy products designed to improve women’s sexual pleasure and health. Aguilera has long used her voice to challenge societal norms around female sexuality, and in her new role, she will continue to promote Playground’s mission of creating…
